A New Framework for Precise Identification of Prostatic Adenocarcinoma

Abstract

Prostate cancer, which is also known as prostatic adenocarcinoma, is an unconstrained growth of epithelial cells in the prostate and has become one of the leading causes of cancer-related death worldwide. The survival of patients with prostate cancer relies on detection at an early, treatable stage. In this paper, we introduce a new comprehensive framework to precisely differentiate between malignant and benign prostate cancer. This framework proposes a noninvasive computer-aided diagnosis system that integrates two imaging modalities of MR (diffusion-weighted (DW) and T2-weighted (T2W)). For the first time, it utilizes the combination of functional features represented by apparent diffusion coefficient (ADC) maps estimated from DW-MRI for the whole prostate in combination with texture features with its first- and second-order representations, extracted from T2W-MRIs of the whole prostate, and shape features represented by spherical harmonics constructed for the lesion inside the prostate and integrated with PSA screening results. The dataset presented in the paper includes 80 biopsy confirmed patients, with a mean age of 65.7 years (43 benign prostatic hyperplasia, 37 prostatic carcinomas). Experiments were conducted using different well-known machine learning approaches including support vector machines (SVM), random forests (RF), decision trees (DT), and linear discriminant analysis (LDA) classification models to study the impact of different feature sets that lead to better identification of prostatic adenocarcinoma. Using a leave-one-out cross-validation approach, the diagnostic results obtained using the SVM classification model along with the combined feature set after applying feature selection (88.75% accuracy, 81.08% sensitivity, 95.35% specificity, and 0.8821 AUC) indicated that the system’s performance, after integrating and reducing different types of feature sets, obtained an enhanced diagnostic performance compared with each individual feature set and other machine learning classifiers. In addition, the developed diagnostic system provided consistent diagnostic performance using 10-fold and 5-fold cross-validation approaches, which confirms the reliability, generalization ability, and robustness of the developed system.

A Novel System for Precise Grading of Glioma

“…Higher b -values produce greater attenuation of the DW-MR signal intensity. The voxel-wise ADC values [ 45 ] at a certain b -value can be calculated as shown in Figure 5 . Subsequently, we set the b -value to 1000 and calculated ADC accordingly for each voxel within the segmented tumor.…”

Identidication of novel biomarkers in non-small cell lung cancer using machine learning

“…Zheng et al developed an integrated radiomic model using the ML method to predict the prognosis of prostate cancer patients 7 . ML methods have also been used to screen for potential biomarkers of prostate cancer and osteosarcoma 8,9 . Support vector machines (SVM), a linear classifier with maximum intervals defined in the feature space, have gradually been applied to machine learning of cancer using its efficient two-class model to classify cancer with high accuracy from a large number of genomes and efficiently extract key genes to achieve high-accuracy, low-error sample classification.…”

Special Issue “Computer Aided Diagnosis Sensors”

“…Holubiac et al [ 5 ] discussed the effect of a strength-training protocol on bone mineral density for postmenopausal women with osteopenia/osteoporosis assessed by dual-energy X-ray absorptiometry (DEXA). Ayyad et al [ 6 ] proposed a new framework for the precise identification of prostatic adenocarcinoma from two imaging modalities.…”